CVI Investments, Inc. 13D/13G Filings for Can-Fite BioPharma Ltd. (CANF)

CVI Investments, Inc. 13D and 13G filings for Can-Fite BioPharma Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
3:23 pm
Unchanged
2021-12-3113GCan-Fite BioPharma Ltd.
CANF
CVI Investments, Inc.2,316,165
3.700%
0
(Unchanged)
Filing
2021-02-16
09:54 am
Sale
2020-12-3113GCan-Fite BioPharma Ltd.
CANF
CVI Investments, Inc.2,316,165
5.000%
-610,665decrease
(-20.86%)
Filing